In the study evaluating Se-allylselenocysteine activity against HT-29 colon cancer cells, the authors observed that a decline in the expression of mTOR was related to an increase in the level of phosphorylated AMPK in the tested cells [41]. The gene discussed is MTOR; the disease is malignant colon neoplasm.